TY - JOUR
T1 - Biospecimen reporting for improved study quality
AU - Moore, Helen M.
AU - Kelly, Andrea
AU - Jewell, Scott D.
AU - McShane, Lisa M.
AU - Clark, Douglas P.
AU - Greenspan, Renata
AU - Hainaut, Pierre
AU - Hayes, Daniel F.
AU - Kim, Paula
AU - Mansfield, Elizabeth
AU - Potapova, Olga
AU - Riegman, Peter
AU - Rubinstein, Yaffa
AU - Seijo, Edward
AU - Somiari, Stella
AU - Watson, Peter
AU - Weier, Heinz Ulrich
AU - Zhu, Claire
AU - Vaught, Jim
PY - 2011/4/1
Y1 - 2011/4/1
N2 - Human biospecimens are subject to a number of different collection, processing, and storage factors that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research utilizing human tissues, it is critical that information regarding the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The Biospecimen Reporting for Improved Study Quality guidelines are proposed as an important and timely resource tool to strengthen communication and publications around biospecimen-related research and help reassure patient contributors and the advocacy community that the contributions are valued and respected.
AB - Human biospecimens are subject to a number of different collection, processing, and storage factors that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research utilizing human tissues, it is critical that information regarding the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The Biospecimen Reporting for Improved Study Quality guidelines are proposed as an important and timely resource tool to strengthen communication and publications around biospecimen-related research and help reassure patient contributors and the advocacy community that the contributions are valued and respected.
UR - http://www.scopus.com/inward/record.url?scp=79953825108&partnerID=8YFLogxK
U2 - 10.1089/bio.2010.0036
DO - 10.1089/bio.2010.0036
M3 - Article
AN - SCOPUS:79953825108
SN - 1947-5535
VL - 9
SP - 57
EP - 70
JO - Biopreservation and Biobanking
JF - Biopreservation and Biobanking
IS - 1
ER -